key: cord-0290694-6ofghy2j
authors: Zuercher, S. J.; Banzer, C.; Adamus, C.; Lehmann, A. I.; Richter, D.; Kerksieck, P.
title: Post-viral mental health sequelae: Systematic review and meta-analysis of prevalence proportions
date: 2021-07-03
journal: nan
DOI: 10.1101/2021.06.29.21259615
sha: 53073c68a92cc61098f64ee7db85e2272a20c76a
doc_id: 290694
cord_uid: 6ofghy2j

Background: Mental health problems (MHP) in COVID-19 patients and survivors were anticipated already during early stages of this pandemic. We aimed to synthesize the prevalence of anxiety, depression, post-traumatic and general distress of major virus epidemics since 2002. Methods: In this systematic review and meta-analysis, we searched PubMed, PsycINFO, and Embase from 2002 until April 14, 2021 for peer-reviewed studies reporting prevalence of MHP in adults with laboratory-confirmed or suspected SARS-CoV-1, H1N1, MERS-CoV, H7N9, Ebolavirus, or SARS-CoV-2 infection. We included studies that assessed MHP with well-validated and frequently used scales. A three-level random-effects meta-analysis for dependent sizes was conducted to account for multiple outcome reporting. We pooled MHP jointly and separately for mild or moderate-to-severe severity by acute (one month), ongoing (one to three month), and post-illness phase (longer than three months). A meta-regression was conducted to test for moderating effects. PROSPERO registration: CRD42020194535. Findings: We identified 59 studies providing a total of 187 effect sizes. Range for sample size (n=14-n=1002), females (22-79%), and mean age (32-72 years). MHP prevalence was higher for mild (35.5-46.3%) compared to moderate-to-severe MPH (17.3-22.3). MHP, in general, decreased from acute to post-illness from 46.3% to 38.8% and for mild and moderate-to-severe from 22.3% to 18.8%, respectively. We found no evidence of moderating effects except for non-random sampling and H1N1 showing higher proportions. Interpretation: MHP decreased over time but were still on a substantial level at post-illness. This highlights a need for rapid access to mental health care and rehabilitation planning in affected individuals.

A large body of evidence from COVID-19 and earlier epidemics such as SARS-CoV-1 and Ebola raised concerns regarding long-lasting neurological and psychological problems in infected individuals. [1] [2] [3] [4] Yet, the pathological processes in which COVID-19 leads to detrimental psychoneurological effects are still largely unknown and are subject to extensive ongoing research. Pathophysiological mechanisms including immune response, vascular damage, detrimental effects of critical illness and side effects from treatments may play an important role. 5 Psychological problems (thereinafter mental health problems [MHP] ), are at least partly attributable to sociodemographic and environmental factors. Infected individuals may suffer from lifethreatening complications with uncertain survival or recovery, social isolation, and reduced access to social support, all of which can lead to loneliness and MHP. 6, 7 Affected individuals may face compromised access to care due to escalating case numbers and overwhelmed health services. Post-illness, survivors may face ongoing symptoms such as reduced physical functioning, fatigue, social and economic issues such as stigmatization with a refusal of services, and reduced working abilities. 1, 3, 8, 9 Mental health problems may also be aggravated by a history of pre-existing mental health problems. 10 As treatment possibilities improve, there is a shift towards physical and psychological long-term effects in affected individuals. Estimating the magnitude of long-lasting mental and physical problems, including mechanisms and risk factors, is critical to estimate individual, societal and economic costs and to facilitate treatment and rehabilitation planning. 11 Results from original studies and reviews estimating MHP prevalence values can be limited in estimating the burden of disease due to a large heterogeneity in study quality, like assessment methods used. 1, 12 We are not aware of a systematic evidence synthesis including patients and survivors of major infections disease epidemics in the last two decades that include severe acute respiratory syndrome coronavirus 1 (SARS-CoV-1), swine flu (H1N1), Middle East respiratory syndrome coronavirus (MERS-CoV), avian influenza (H7N9), Ebolavirus, and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In the present meta-analysis, we aimed to estimate the overall MHP prevalence and the prevalence proportion of anxiety, depression, posttraumatic stress, and general distress with validated and widely used scales in suspected and laboratoryconfirmed patients and survivors. We used a meta-regression to investigate potential moderating effects on the overall MHP proportions.

(PHQ-15 Scale). Prevalence values were further stratified by follow-up timepoint and severity defined as at least mild symptoms or at least moderate-to-severe symptoms cut-off by assessment instruments (appendix p 5).

Quality was appraised independently by SJZ, CA, CB, and PK using eight items of the nine criteria version of the Joanna Briggs Institute Critical Appraisal Checklist for Studies Reporting Prevalence Data. 15 Each item was rated with yes, no, or unclear and covered sampling frame, sampling/recruitment, sample size, subjects and setting description, coverage, standardized procedures, transparent statistical analyses, and response rate. We excluded the item on valid assessment methods as we only included studies using well-established assessment scales (e.g., PHQ). To the best of our knowledge, there is no published recommendation of weighting and scoring. 15 We therefore binarized each quality item into yes/no (no or unclear) and calculated the quality achieved in percent (possible range from zero to eight out of a maximum of eight). We classified at least seven points (>87%) as good to excellent, five to six (63-75%) as moderate, less than four (≤50%) as poor.

Discrepancies were resolved through discussion. Average inter-rater agreement across all items ranged from 80·0 to 96·7% (Cohens Kappa; 0·75 [95% CI 0·58-0·92] to 0·93 [95% CI 0·83-1·0]).

We conducted a random-effects meta-analysis and meta-regression for dependent and non-dependent effect sizes for point prevalence values and moderators of overall MHP and by MHP domains separately including anxiety, depression, post-traumatic stress, general distress, and other MHP such as somatization. All estimates were separated by severity (mild or moderate-to-severe) (appendix p 5) and by follow-up time. In the case of dependent effect sizes for studies reporting multiple outcomes in the same participants, a three-level mixedeffects model was fitted (taking withing study variation into account). 16 To pool prevalence with 95% CIs, each study's proportion estimate was transformed by the Freeman-Tukey double-arcsine transformation for metaanalysis and back-transformed after model fitting. 17 We used I 2 to determine heterogeneity for analysis in nondependent effect sizes. In dependent effect sizes, the distribution of total variance (%) attributed to between and within-study variance was estimated. 18 Meta-regression was conducted on arcsine transformed proportions due to better statistical properties as compared to untransformed proportions. Restricted maximum likelihood was used for parameter estimation. The threshold for significance was set to p<0·05. Statistical analyses were conducted in R (version 4.0.3) using the metafor package. 19 Sensitivity analyses were performed by the investigation of influential effect-sizes using DFBETAS and Cook's distance. 19 To analyze the data, we conducted the following a-priori defined steps. First, we estimated the overall pooled prevalence, including all effect sizes (excluding general distress as a generic measure of general distress) and by MHP domains separately. All estimations were stratified by mild or moderate-to-severe severity and acute, ongoing and post-illness follow-up timepoint. Second, a meta-regression on the overall mild and moderate-tosevere MHP values was conducted including follow-up timepoint, sex, age, education, history of a mental health condition, health-care workers, duration of hospitalization, intensive care treatment, type of treatment, response rate, sampling method, world region, and epidemic type as moderators. All moderators were tested individually while adjusting for follow-up timepoint in months. A complete model to test all moderators jointly was not possible due to the substantial missingness patterns.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint

The systematic search yielded 3304 records, of which 59 (61 samples) were included in the analyses (Figure 1 ).

The number of individuals ranged from 14 to 1´002, with a proportion of females ranging from 22% to 79% and mean/median age from 32-72 years. A total of 187 effect sizes for mild and moderate-to-severe MHP prevalence values were reported, with one study that assessed samples in different countries 20 and two that had overlapping samples. 21, 22 Studies covered China (n=20), Asia excluding China (n=14), Europe (n=17), Africa (n=6), and America (n=3). 42 (71%) studies investigated SARS-CoV-2, eight (14%) SARS-CoV-1, four (7%) MERS-CoV, four (7%) Ebolavirus, and one (2%) H1N1, while no study covered H7N9 ( Table 1) . Time elapsed since treatment/data collection ranged from 0 to about 40 months, with 116 effect sizes providing data for acute, 35 for ongoing, and 36 post-illness stages, respectively. Studies rarely reported complete data on all descriptive or moderator variables leading to a substantial amount of missing data. While female/male ratio was provided regularly (>98%), other variables such as (history of a psychiatric condition, percent health care workers) were not regularly provided.

Overall, 18 studies showed an excellent, 15 studies a moderate and 26 a poor quality on the appraisal scale ( Table 1 and appendix pp 6-7).

Pooled prevalence of mild or moderate-to-severe MHP including all domains jointly and separately by all timepoint of follow-up are shown in Figure 2 and Table 2 . Studies contributing to summary effects are shown in the supplementary material (appendix pp 8-13). Mild problems occurred at a substantially higher rate as moderate-to-severe MHP. We found a general downwards trend from the acute to ongoing/post-illness stage.

This trend was also seen in the meta-regression including follow-up time as a moderator. The overall MHP significantly decreased from acute to the post-illness stage for mild (Coeff. arcsine -0·18 [95% CI -0·31 to -0·06], p=0·0038) as well as for moderate-to-severe (Coeff. arcsine -0·15 [95% CI -0·25 to -0·04], p=0·0080) severity.

However, this trend was not significant for the ongoing vs. acute stage (appendix p 14). Meta regression including mild or moderate-to-severe domains of anxiety, depression, and post-traumatic stress as outcomes, separately (data not shown), yielded a significant decrease in moderate anxiety from acute to post-illness only (Coeff. arcsine -0·14 [95% CI -0·26 to -0·02], p=0.0228).

Aside from a decreasing time trend, prevalence values were still substantial over all domains at post-illness phase for mild 38·8% [95% CI 33·6−44·1] and moderate severity 18·8% [95% CI 13·4−25·0]. Likewise, prevalence proportions for mild severity by domain at post-illness ranged from 33·5% [95% CI 24·8−42·7] to 43·5% [95% CI 34·1−53·1] for anxiety and post-traumatic stress, respectively. Moderate-to-severe MHP ranged from 12·1% [95% CI 5·3−21·1] to 39·1% [25·7−53·2] for anxiety and post-traumatic stress, respectively. Data for pooling general distress was available only in the ongoing stage. Pooling for somatization, and general distress (acute, post-illness), was not possible since only single effect-sizes were available (appendix. p 13).

Generally, there were many more effect sizes available for the acute phase, especially for depression and anxiety and less for the ongoing or post-illness phases ( Table 2) . To emphasize, the estimates for mild or moderate posttraumatic stress were based on very little data (two effect sizes), while the majority of estimators showed substantial heterogeneity with a significant part of variance that could be attributed to between and/or withinstudy heterogeneity (dependent effect sizes). Sensitivity analyses did not change the interpretation.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint domains jointly. All moderatos were tested separately and adjusted for follow-up time in months (appendix p 14). We found no evidence of moderating effects for sex, age, education, history of a psychologic condition, health care workers, duration of hospitalization, treatment in ICU, type of treatment, response rate, and worldregion. In contrast, we found some evidence for lower mild MHP proportions in random vs. non-random sampling methods (Coeff. arcsine -0·16 [95% CI -0·28 to -0·04], p= 0·0083) and higher proportions of moderate-tosevere MHP in H1N1 vs. SARS-CoV-2 (Coeff. arcsine 0·39 [95% CI 0·003 to 0·78], p=0·0483). However, the contrast between H1N1 and SARS-CoV-2 should be interpreted cautiously since it is based on very little data.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. .

It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint 3 Within study variance displays the amount of within study variances attributed to dependent effect sizes within studies where a three-level meta-analysis was calculated . CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint

We conducted a systematic review and meta-analysis that explored the prevalence proportions of acute, ongoing and post-acute mental health sequelae after infection with SARS-1, MERS, Ebola, H1N1 or SARS-Cov-2 viruses. We included 59 studies providing a total 187 effect sizes in the analysis. In general, we found that mild psychological problems had higher prevalence proportions than moderate to severe conditions. We also found that acute infections were associated with higher prevalence proportions of mental health problems than postillness. This, however, was not found uniformly across all time-points and mental health problem severity groups.

The overall picture suggests that any mild and moderate-to-severe psychological conditions will be experienced by 39% and 19% of infection survivors for longer than 12 weeks. Likewise, anxiety, depression, and posttraumatic stress, and general distress were substantial beyond the acute phase. Combined, these results show that a considerable proportion of infection survivors will suffer from mental health problems severely for a longer time.

Our results support meta-studies on earlier epidemic outbreaks. A meta-analysis with Chinese publications on SARS-1 found a decrease of mental health problems over time but reported at 12 months post-hospital discharge a level of average distress above population norms. 77 A systematic review on post-Ebola virus disease studies gathered publications that found considerable depression prevalence and other psychological sequelae in Ebola survivors . 78 Our results provide more precision than earlier meta-analytical results from COVID-19 meta-analyses.

A not yet peer-reviewed study on various long-term sequelae of COVID-19 reported prevalence of 12% for anxiety and 13% for depression. 9 It is, however, unclear at what time this was assessed. A meta-analysis on early neurological and neuropsychiatric studies (published until July 2020) reported point prevalence values for anxiety of 15.9% and of 23.0% for depression. 1 Our results similarly fall in that range. However, milder mental health conditions are somewhat more prevalent and can have detrimental effects as well.

The moderator analysis has shown that post-illness COVID-19 mental health sequelae are not fundamentally different compared to consequences of earlier virus epidemics. While the information on the post-viral health detriments was available from earlier infection outbreaks, it is somewhat astonishing that the risks of longer-term conditions were overlooked in the early days of the pandemic and that it took quite some time to receive the science and media attention it now has. 79 The moderator analysis has also shown effects for the time point and for the sampling method in particular. This suggests that methodological details and study quality are very important for assessing the contribution of single studies. In general, and as reported from earlier epidemiological studies on mental health effects of epidemics, 80 the study quality has to be evaluated as mixed. While about 56% reached a moderate to high study quality about 44 per cent showed a poor quality. Studies frequently suffered from non-transparency regarding sampling frame, recruitment, sample size and provided only a poor description of the study sample and setting and showed low response rates. Furthermore, at least one third showed an unclear or insufficient coverage of the identified sample. In contrast, studies predominantly assessed MHP in a standardized way and clearly described how prevalence was calculated.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint Our findings highlight the importance of mental health interventions generally, but at an acute stage of infection specifically. First, clear information about the disease (e.g., infection rates, quarantine, vaccination) is not only important to address uncertainty and fear but also to improve mental health literacy within the population. 81 Therefore, public communication should also integrate virus-and pandemic-related mental health issues.

Furthermore, multidisciplinary mental health support (that includes psychiatrists, clinical psychologists, mental health nurses and other professions) should be delivered at an early stage. 82 Access to mental health interventions could be supplemented by digital health online and smartphone technologies if face-to-face treatment is limited. 81, 83, 84 A clinical screening for psychiatric symptoms would ideally be an integrative element already within the acute stage. Therefore, mental health awareness appears to be an important aspect within primary care and emergency departments in particular. Moreover, social support for impaired individuals should be strengthened. This could be supported by prevention strategies that include community-based collaboration among education and employment services, families and housing, and voluntary work. 81

The main strength of this research is that it is a large systematic review and meta-analysis that encompasses the major virus outbreaks within the last 20 years. Moreover, this research differentiates between diagnoses, timepoints and moderators that allows a comprehensive view regarding the prevalence values of MHP.

This research also has some limitations. Firstly, most studies within this systematic review and meta-analysis lack representativeness. Often, patients with unstable conditions or those within ICU units, or those not hospitalized were not included. This selection bias potentially led to an underestimation/overestimation of the prevalence values. Further, many original studies were generally of poor or moderate quality with incomplete data or a lack of random or complete sampling. This might be due to the urgent need for conducting such studies in a pandemic situation. Secondly, this meta-analysis methodology was limited by the fact that further wellvalidated instruments (e.g., State-Trait Anxiety Inventory) were not included in this research. The metaregression should be interpreted cautiously since many studies did not provide data on all moderators. Furthermore, it was not possible to include all hypothetical moderators. Specifically, the physical disease severity and the burden of late physical effects were not covered as this was often not reported within studies.

This systematic review and meta-analysis explored the prevalence proportions of acute, ongoing, and post-acute mental health problems after a major virus outbreak within the last 20 years. Generally, mild mental health problems had higher prevalence proportions than moderate to severe conditions. Moreover, most mental health problems had a higher prevalence proportion at an acute infection stage compared to a post-acute stage. Our findings further underline the importance of the study quality that is not often given within the original studies.

Therefore, guidelines aiming to advice assessment and reporting acute and post-illness MHP in a standardized way are urgently needed. Overall, this research highlights the fragility of mental health after infection from a pandemic virus. Additionally, it emphasizes the need for the early provision of mental health interventions that follow long-lasting post-viral mental health sequelae.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint

We declare no competing interests.

SJZ and DR conceived and designed the study. SJZ, CB, CA, and PK conducted the literature search and selection, data extraction, and appraisal of study quality. SJZ conducted the statistical analyses. SJZ, PK, DR and AIL wrote the first draft of the manuscript. All authors contributed to data interpretation, manuscript revisions and approved the final version of the manuscript.

No funding.

. CC-BY-NC-ND 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review)

The copyright holder for this preprint this version posted July 3, 2021. ; https://doi.org/10.1101/2021.06.29.21259615 doi: medRxiv preprint

Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic

Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis

Neuropsychological long-term sequelae

of Ebola virus disease survivors -A systematic review

Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA

Neurological update: COVID-19

Prevalence of depression and its association with quality of life in clinically stable patients with COVID-19

The psychological impact of quarantine and how to reduce it: rapid review of the evidence

Psychological impact on SARS survivors: Critical review of the

More than 50 Long-term effects of COVID-19: a systematic review and meta-analysis. medRxiv : the preprint server for health sciences

Mental health status of people isolated due to Middle East Respiratory Syndrome

Quality assessment of prevalence studies: a systematic review

Prevalence of Mental Health Problems During Virus Epidemics in the General Public, Health Care Workers and Survivors: A Rapid Review of the Evidence

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Assink M, Wibbelink CJM. Fitting three-level meta-analytic models in R: A step-by-step tutorial

Conducting Meta-Analyses in R with the metafor Package

Mental health among Ebola survivors in Liberia, Sierra Leone and Guinea: results from a cross-sectional study

Posttraumatic stress after SARS

Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS)

Relationship between sleep quality and the psychological status of patients hospitalised with COVID-19

Prevalence of anxiety, depression and post-traumatic stress disorder among Ebola survivors in northern Sierra Leone: a cross-sectional study

Psychological outcomes after hospitalization for COVID-19: data from a multidisciplinary follow-up screening program for recovered patients

Prevalence and predictors of posttraumatic stress disorder, depression and anxiety among hospitalized patients with coronavirus disease 2019 in China. BMC Guinea (Postebogui): an observational cohort study. The Lancet Infectious diseases

Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: A mixed-method study

Neurological and psychiatric presentations associated with COVID-19

Impact of COVID-19: urging a need for multi-domain assessment of COVID-19 inpatients

Is COVID-19 Associated With Posttraumatic Stress Disorder?

Factors related to mental health of inpatients with COVID-19 in Wuhan

Persistent Symptoms, and Depression in People Infected with COVID-19 in Bangladesh

Clinical characteristics and online mental health care of asymptomatic or mildly symptomatic patients with coronavirus disease 2019

Effects of centralized isolation vs. home isolation on psychological distress in patients with COVID-19

Evaluation of the relationship between perceived social support, coping strategies, anxiety, and depression symptoms among hospitalized COVID-19 patients

The Psychological Burden of COVID-19 Stigma: Evaluation of the Mental Health of Isolated Mild Condition COVID-19 Patients

Telephone based Interventions for Psychological Problems in Hospital Isolated Patients with COVID-19. Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of

Effect of Psychological-Behavioral Intervention on the Depression and Anxiety of COVID-19 Patients

Quality of life and psychological status in survivors of severe acute respiratory syndrome at 3 months postdischarge

Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up

Depression as a Mediator of Chronic Fatigue and Post

Traumatic Stress Symptoms in Middle East Respiratory Syndrome Survivors

The Associated Factors of Anxiety and Depressive Symptoms in COVID-19 Patients Hospitalized in Wuhan

A(H1N1)-associated severe ARDS

Long-term psychiatric morbidities among SARS survivors

Postintensive Care Syndrome in Survivors of

Critical Illness Related to Coronavirus Disease 2019: Cohort Study From a New York City Critical Care Recovery Clinic

Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors

An online observational study assessing clinical characteristics and impacts of the COVID-19 pandemic on mental health: a perspective study from Bangladesh

Four-Month Clinical Status of a Cohort of Patients After 59

Depression Among Recovered African Americans with COVID-19-Associated Respiratory Failure

Posttraumatic stress disorder and depression of survivors 12 months after the outbreak of Middle East respiratory syndrome in South Korea

Depression, Anxiety, and Acute Stress Disorder Among Patients Hospitalized With COVID-19: A Prospective Cohort Study

Behavioral and sociodemographic predictors of anxiety and depression in patients under epidemiological surveillance for COVID-19 in Ecuador

Psychiatric morbidity and protracted symptoms after COVID-19

Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge

Neurological outcome and quality of life three months after COVID-19: a prospective observational cohort study. European journal of neurology 2021. 66. Ş ahan E, Ünal SM, Kırpınar İ . Can we predict who will be more anxious and depressed in the COVID-19 ward?

Depression and Coping Among COVID-19-Infected Individuals After 10 Days of Mandatory in-Hospital Quarantine

The effects of disease severity, use of corticosteroids and social factors on neuropsychiatric complaints in severe acute respiratory syndrome (SARS) patients at acute and convalescent phases

Mood, anxiety and olfactory dysfunction in COVID-19: evidence of central nervous system involvement? The Laryngoscope 2020. 70. van den Borst B

Telepsychiatric Evaluation of SARS-CoV-2 Patients

A psychological investigation of coronavirus disease 2019 (COVID-19) patients in mobile cabin hospitals in Wuhan

The relationship between resilience, anxiety and depression among patients with mild symptoms of COVID-19 in China: A cross-sectional study

Mental health outcomes of coronavirus infection survivors: A rapid meta-analysis

Post-Ebola psychosocial experiences and coping mechanisms among Ebola survivors: a systematic review

The four most urgent questions about long COVID

Mental health problems in the general population during and after the first lockdown phase due to the SARS-Cov-2 pandemic: rapid review of multi-wave studies

How mental health care should change as a consequence of the COVID-19 pandemic

Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed

Mental Health Strategies to Combat the Psychological Impact of COVID-19 Beyond Paranoia and Panic

Online mental health services in China during the COVID